Saturated Fatty Acid-Based In Situ Forming Matrices for Localized Antimicrobial Delivery

Takron Chantadee1, Wichai Santimaleeworagun2, Yaowaruk Phorom3

  • 1Department of Pharmaceutical Technology, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand.

Pharmaceutics
|August 29, 2020
PubMed

Insights

New fatty acid-based matrices effectively deliver vancomycin HCl (VCM) for treating antibiotic-resistant infections like MRSA. These injectable systems offer sustained VCM release and potent antimicrobial activity against various pathogens.

Area of Science:

  • Biomaterials Science
  • Pharmaceutical Sciences
  • Infectious Diseases

Background:

  • Antibiotic resistance, particularly Methicillin-resistant Staphylococcus aureus (MRSA), poses a significant global health challenge.
  • Localized infections require effective drug delivery systems to combat resistant pathogens.
  • Injectable in situ forming matrices offer potential for sustained drug release at infection sites.

Purpose of the Study:

  • To develop and characterize biocompatible, injectable in situ forming matrices for localized delivery of vancomycin HCl (VCM).
  • To evaluate the influence of fatty acid chain length on matrix properties, VCM release kinetics, and antimicrobial efficacy.
  • To assess the potential of these novel matrices for treating local Gram-positive infections.

Main Methods:

  • Synthesis and characterization of fatty acid-based (C8-C18) in situ forming matrices.
  • Incorporation of vancomycin HCl (VCM) into the matrices.
  • Evaluation of matrix physical properties (viscosity, pH, injectability), phase transformation, VCM release kinetics (Higuchi model), and antimicrobial activity against S. aureus, MRSA, E. coli, and C. albicans.

Main Results:

  • Fatty acid-based matrices exhibited low viscosity, suitable pH, and high injectability.
  • Matrices demonstrated controlled VCM release over seven days, with C12-C16 formulations showing prolonged release (56-85% cumulative release).
  • Formulations displayed significant antimicrobial activity against tested bacterial and fungal strains, including MRSA.

Conclusions:

  • Antisolvent-induced, fatty acid-based in situ forming matrices are effective for localized, sustained delivery of vancomycin HCl.
  • The developed system shows promise as a potential local delivery strategy for treating Gram-positive infections.
  • Further research could explore applications in treating localized infections in joints, eyes, and surgical sites.